Moreover, women carrying pathogenic BRCA1 mutations exhibit higher progesterone levels compared to those at average risk [74], suggesting that continuous RANK/RANKL signaling due to elevated progesterone levels in BRCA1 carriers could be a potential mechanism contributing to the development of breast cancer. Here, TNFRSF11A is linked to breast cancer.